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Abstract
Background: Within trauma care measurement of changes in health-related quality of life (HRQL) is used in
understanding patterns of recovery over time. However, conventionally-measured change in HRQL may not always
reflect the change in HRQL as perceived by the patient. Recall bias and response shift may contribute to disagreement
between conventional and retrospective change in HRQL. This study aimed to measure conventional and retrospective
change of HRQL and assess to which extent recall bias and response shift contribute to disagreement between these
two in a heterogeneous sample of adult trauma patients.
Methods: A sample of trauma patients (≥18 years) who attended the Emergency Department and were admitted to
an Intensive Care unit or ward of one of ten Dutch hospitals received postal questionnaires 1 week (T1) and 3months
(T2) post-injury. At T1 and T2 participants completed the EQ-5D-3 L and EQ-VAS for their current health status. At T2
participants also filled out a recall and then-test regarding their health status at T1. The responses were used to assess
conventional and retrospective change, recall bias and response shift. Wilcoxon signed rank tests were used to
examine conventional and retrospective change on a group level. The intraclass correlation coefficient (ICC) was used
to examine individual agreement between conventional and retrospective change. Uni- and multivariate linear
regression analysis were used to investigate the association between background factors and recall bias and response
shift.
Results: The EQ-5D-3 L, recall and then-test were completed by 550 patients. Mean EQ-5D-3 L summary score
improved from 0.48 at T1 to 0.74 at T2. Mean EQ-VAS score improved from 56 at T1 to 73 at T2. Retrospective change
was significantly higher than conventional change (EQ-5D-3 L: Z = -5.2, p < 0.05; EQ-VAS Z = -2.1, p < 0.05). Pairwise
comparisons showed that agreement between conventional and retrospective change was fair (EQ-5D-3 L: ICC = 0.49;
EQ-VAS: ICC = 0.48). For EQ-5-3 L response shift was significantly higher than recall bias (Z = − 4.5, p < 0.05). Patients
with traumatic brain injury (TBI), severe injury and/or posttraumatic stress symptoms were more susceptible to recall
bias and response shift.
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Conclusions: We conclude that, compared to recall bias, response shift contributed more to the disagreement
between conventional and retrospective change in EQ-5D-3 L summary score and EQ-VAS. Predictable subgroups of
trauma patients were more susceptible to recall bias and response shift.
Keywords: Health-related quality of life, Mental recall, Wounds and injuries, Brain injuries traumatic
Background
A well-studied outcome in trauma care is health-related
quality of life (HRQL) [1]. HRQL is used to estimate the
impact of an injury on a patient’s life, and enables to
evaluate quality of care in patients [2]. Measurement of
change in HRQL, individual or aggregate, has been used
to evaluate health interventions in a wide range of con-
ditions and populations (e.g. [3–7]). Inaccurate measure-
ment of change in HRQL may therefore affect clinical
practice and health care, and ultimately the quality of
care and HRQOL of patients. In an observational con-
text this change provides insight into patterns of recov-
ery over time [8, 9]. The understanding of recovery
patterns supports the clinician in setting expectations,
and the timely identification of specific patient groups
with lower HRQL over time. Knowing who faces a poor
prognosis may guide the development and application of
targeted interventions to halt this development.
However, conventionally-measured change in HRQL
may not always reflect the change in HRQL as perceived
or experienced by the patient. Conventionally-measured
change in HRQL is defined by the difference between
the direct measurements of HRQL at two consecutive
occasions. The patient’s perceived change in HRQL is
defined as the difference between the directly measured
current HRQL and the HRQL as stated by the patient to
be the HRQL on a specified previous occasion. Indeed,
McPhail showed that agreement between conventional
change and retrospective change in HRQL was not
strong. A large proportion of the disagreement was at-
tributed to so-called recall bias [10]. Recall bias is de-
fined as a systematic measurement error, due to
memory decay, that is the fading of memory with time.
From the current standpoint, past health may be memo-
rized as more deteriorated or better than it actually was;
the direction depending on psychological mechanisms
which keep better or worse memories better alive [11].
The magnitude of recall bias may depend on the scale
that is used to measure HRQL, where subjective scales,
such as the visual analogue scale (VAS), may easier be
distorted than classification-like scales, like the EQ-5D
[12, 13]. Recall bias of HRQL has been observed among
patients with e.g. multiple sclerosis, psoriasis, cancer, in-
jury and total hip arthroplasty [14–17] A study among
patients with traumatic brain showed that recall bias was
stronger in patients with high symptoms, which include
memory problems [18]. This indicates that the size of re-
call bias may be higher among patients who experience
memory problems compared to their counterparts.
Response shift may also contribute to disagreement
between conventional and retrospective change in
HRQL. Response shift is a true change of a patients’ per-
spective towards the targeted construct, caused by a
change in internal standards, a change in values, and/or
a redefinition of the construct [19, 20]. This may change
the direction of change. Among trauma patients re-
sponse shift may occur between multiple post-injury
HRQL measurements due to patients adapting to their
ill health [19, 20]. However, the magnitude of response
shift may vary across type and severity of injury. A study
among multiple sclerosis patients showed that being
more disabled was associated with a change in internal
standards with regards to certain HRQL dimensions
[21], indicating that response shift may be stronger
among patients with more severe injuries. Consequently,
the contribution of response shift to disagreement be-
tween conventional and retrospective change may also
vary across subgroups of trauma patients.
McPhail et al. were the first to investigate response
shift and recall bias simultaneously in a sample of 101
elderly hospitalized patients [10]. The investigators ar-
gued that the contribution of response shift and recall
bias may vary across other patient groups. This may par-
ticularly be the case for trauma patients, since injuries
comprise of heterogeneous patterns of ill-health and
may affect patients of all age groups.
The aims of this study were to measure conventional
and retrospective change of HRQL, measured with the
EQ-5D-3 L and the EQ-VAS, and to assess to which ex-
tent recall bias and response shift contribute to disagree-
ment, in a heterogeneous sample of trauma patients.
Hypotheses
We tested the following hypotheses:
– Agreement between conventional and retrospective
change of HRQL, as measured with EQ-VAS, is
lower compared to the agreement if HRQL was
measured with EQ-5D-3 L, because recall bias and
response shift more easily distort subjective scales
(like a VAS) than a classification-like scale like EQ-
5D-3 L.
Haagsma et al. Health and Quality of Life Outcomes          (2020) 18:157 Page 2 of 13
– Agreement between conventional and retrospective
change of HRQL is higher among trauma patients
with less severe injuries (ISS < 16), because low
impact trauma requires less adaptation to ones
(final) health status compared severe trauma.
– Recall bias rather than response shift causes
disagreement between conventional and
retrospective change because with the time lapse
chosen (3 months) memory problems affecting recall
are no longer trivial.
– In older patients, in patients with traumatic brain
injury (TBI) and patients with posttraumatic stress
disorder (PTSD) the size of recall bias is higher
compared to their counterparts, because these
patients experience more memory problems.
Methods
Study design
This study utilizes data from a registry-based study on
injury patients in Noord-Brabant (2.5 M inhabitants), the
Netherlands. This prospective longitudinal cohort study,
called the Brabant Injury Outcome Surveillance (BIOS)
study, assessed outcomes in trauma patients, admitted to
one of the ten hospitals in the Noord-Brabant region in
the Netherlands [22]. The BIOS study includes multiple
HRQL measurements up to 24 months after injury. Re-
sponse shift items and recall questions were intentionally
included in the 3 month follow-up survey. Ethical ap-
proval for the observational data analysis of this study
was received from the Medical Ethics Committee Bra-
bant (NL50258.028.14).
BIOS study population
All trauma patients (≥18 years), who attended the Emer-
gency Department (ED) and were admitted to an Inten-
sive Care unit (ICU) or ward of one of the ten hospitals
between November 2015 and November 2016, and who
were discharged alive, qualified for inclusion. Patients
were excluded if they were unable to understand or an-
swer Dutch language questionnaires, when they had a
pathological fracture due to a primary malignancy, or
when they had no permanent address [22].
The eligible patients were invited to participate in the
BIOS study via a postal invitation one week after admis-
sion to hospital. This invitation was accompanied by an
informed consent form and the first survey (T1). For this
procedure ethical permission is obtained. Non-
responders received a telephone call to discuss their par-
ticipation. The 3 month follow up survey (T2) was sent
to the patient if consent and the completed T1 survey
were received by the researchers. For present study, we
included data from patients who completed both
surveys.
Self-report measures
T1 included questions on patient characteristics (e.g. age
and gender), and 19 items regarding the presence of one
or more chronic diseases (e.g. diabetes) prior to the in-
jury to assess comorbidity [23]. If a patient suffered from
one or more chronic disease(s) additional to the injury
that qualified for inclusion, he/she was defined as having
comorbidity [24]. Level of education was divided in three
categories: low, middle or high. For patients classified as
low level the highest level of education obtained was no
education, primary school or prevocational education.
Patients classified as middle level followed at best sec-
ondary or vocational education, and patients classified as
high completed professional higher education or univer-
sity level. Both surveys (T1, T2) included the EQ-5D-3 L.
The EQ-5D-3 L is a standardized generic HRQL meas-
ure [25]. The EQ-5D-3 L covers five dimensions: mobil-
ity, self-care, usual activities, pain/discomfort, and
anxiety/depression and a visual analogue scale (EQ-
VAS) [25]. The five dimensions have three response op-
tions: no problems, moderate problems, extreme prob-
lems [26]. The ordinal scores on the dimensions can be
used in a descriptive analysis, but may also be used as an
input to calculate an EQ-5D-3 L summary score combin-
ing all dimensions, ranging from 0 (death) and 1 (full
health) [27]. For few health states considered worse than
death the summary score can have a value lower than
zero. The EQ-VAS consists of a scale from 0 (worst im-
aginable health) to 100 (best imaginable health) and
measures the patient’s self-rated health in a subjective
way. Apart from the complete EQ-5D-3 L, the T2 ques-
tionnaire also included the so-called ‘recall’ and the
‘then’ test. The recall test asked patients to report what
they remember to have reported on the EQ-5D-3 L on
the previous occasion (T1). The then test asked patients
to report how they believe now what their health status
was at previous assessment (T1). Both the recall test and
then test consisted of six items: five EQ-5D-3 L items
and the EQ-VAS.
The T2 survey also included the impact of event scale
(IES) [28]. The IES is a validated self-report instrument
that uses 15-items questionnaire to assess stress symp-
toms caused by a traumatic event. Each item is scored
on a 4-point scale (0, 1, 3, 5 points), where 0 refers to
“not at all” and 5 refers to “extremely”. The total IES-
score ranges from 0 (no meaningful impact into any dir-
ection) to 75 (severe impact event on all 15 items).
PTSD is assumed to be present if IES-score exceeds 35
[29].
Injury data
Apart from the self-report data, clinical injury data of in-
cluded trauma patients were available from the Brabant
Trauma Registry. All BIOS hospitals also participate in
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this registry. Injury data comprised the Injury Severity
Score (ISS) [30] and the Abbreviated Injury Scale (AIS)
[31]. The AIS classifies the severity of a trauma via an
anatomic scale and it scores the type, location and sever-
ity of each injury that was sustained by a patient. The
AIS score of the three most severely injured body re-
gions are squared and summed to an ISS. The ISS is an
accepted summary score for the severity of a trauma,
and ranges from 1 to 75. A major trauma is assumed to
be present if the ISS exceeds 15 [32]. The ISS was auto-
matically calculated based on the AIS scores that were
registered in the Brabant Trauma Registry.
Data analysis
SPSS version 23 was used for all analyses. We performed
a non-response analysis to study whether responders dif-
fered from non-responders. Mann Whitney U tests were
used for continuous variables and Chi-square tests for
categorical variables. Descriptive statistics were used to
assess the sample characteristics, and EQ-5D-3 L dimen-
sion, EQ-5D-3 L summary scores and EQ-VAS scores.
T1 health outcomes were compared between sub-
groups: males vs. females, age < 65 vs. ≥65 years, absence
vs. presence of pre-existing comorbidity, absence vs.
presence of traumatic brain injury (TBI), ISS < 16 vs.
ISS ≥ 16, and absence vs. presence of PTSD using Mann
Whitney U tests. Similarly, Kruskal Wallis test was used
to compare outcomes according to educational attain-
ment (three levels).
The following equations were used to calculate con-
ventional and retrospective change in HRQL:
Conventional changeEQ−5D summary score T1;T2 ¼ EQ−5D−3L
summary scoreT2  EQ−5D−3L summary scoreT1
ð1Þ
Where EQ-5D-3 L summary scoreT2 and EQ-5D-3 L
summary scoreT1 are the directly measured EQ-5D-3 L
at T1 and T2, respectively.
Conventional changeEQ−VAS T1;T2 ¼ EQ−VAST2  EQ−VAST1
ð2Þ
Where EQ-VAST2 and EQ-VAST1 are the directly
measured EQ-VAS scores at T1 and T2, respectively.
Retrospective changeEQ−5D summary score T1;T2 ¼ EQ−5D−3L
summary scoreT2  EQ−5D−3L then test
ð3Þ
Where EQ-5D-3 L summary scoreT2 is the directly
measured EQ-5D-3 L at T2 and EQ-5D-3 L then test is
the EQ-5D-3 L summary score of how the respondents
believed their EQ-5D-3 L health status was at previous
assessment (T1).
Retrospective changeEQ−VAS T1;T2 ¼ EQ−VAST2  EQ−VAS then test
ð4Þ
Where EQ-VAST2 is the directly measured EQ-VAS
score at T2 and EQ-VAS then test is the EQ-VAS score
of how the respondents believed their EQ-VAS score
was at previous assessment (T1).
See Fig. 1 for a schematic overview of the calculations
of conventional and retrospective change, recall bias and
response shift.
Wilcoxon signed rank tests were used to compare con-
ventional and retrospective change in EQ-5D-3 L sum-
mary scores and EQ-VAS scores for the total sample as
well as for subgroups (males vs. females, age < 65 vs.
≥65 years, absence vs. presence of pre-existing comor-
bidity, absence vs. presence of traumatic brain injury
(TBI), ISS < 16 vs. ISS ≥ 16, and absence vs. presence of
PTSD). It was examined whether conventional and
retrospective change in EQ-5D-3 L summary scores and
EQ-VAS scores differed for the different subgroups, and
whether this was in accordance to our hypotheses. We
calculated the intraclass correlation coefficient (ICC) to
assess agreement between conventional and retrospect-
ive change on patient level [33]. We calculated the ICC
for the whole group, and for subgroups (age, gender,
educational level, comorbidity status, ISS category and
PTSD symptoms). ICC was defined as poor (< 0.40), fair
(0.40–0.59), good (0.60–0.74) or excellent (0.75–1.00)
[34].
Recall bias and response shift were calculated with the
following equations:
Recall biasEQ−5D summary score ¼ EQ−5D−3L recall test
EQ−5D−3L summary scoreT1
ð5Þ
Where EQ-5D-3 L recall test is the EQ-5D-3 L sum-
mary score of the EQ-5D-3 L health status that the re-
spondents remember to have reported at the previous
assessment (T1) and EQ-5D-3 L summary scoreT1 is the
directly measured EQ-5D-3 L at T1.
Recall biasEQ−VAS ¼ EQ−VAS recall test EQ−VAST1
ð6Þ
Where EQ-VAS recall test is the EQ-VAS score that
the respondents remember to have reported at the previ-
ous assessment (T1) and EQ-VAST1 is the directly mea-
sured EQ-VAS at T1.
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Response shiftEQ−5D summary score ¼ EQ−5D−3L then test
EQ−5D−3L summary scoreT1
ð7Þ
Where EQ-5D-3 L then test is the EQ-5D-3 L sum-
mary score of how the respondents believed their EQ-
5D-3 L health status was at previous assessment (T1)
and EQ-5D-3 L summary scoreT1 is the directly mea-
sured EQ-5D-3 L at T1.
Response shiftEQ−VAS ¼ EQ−VAS then test EQ−VAST1
ð8Þ
Where EQ-VAS then test is the EQ-VAS score of how
the respondents believed their health status was at previ-
ous assessment (T1) and EQ-VAST1 is the directly mea-
sured EQ-VAS at T1.
Wilcoxon signed rank tests were used to examine the
differences between response shift and recall bias. Differ-
enced were also studied on a subgroup level in order to
examine whether recall bias and response shift differs
between the subgroups defined. To estimate the role of
background factors in recall bias and response shift re-
spectively, we predicted recall bias and response shift
from the socio-demographic factors (age, gender, educa-
tion), TBI (yes or no), injury severity level (ISS as a con-
tinuous variable) and PTSD symptoms (IES-score as a
continuous variable). Straightforward univariate and
multivariate linear regression analysis were applied, with
backward selection (deselection criterion p < 0.10) were
used to investigate the association between socio-
demographics, comorbidity, TBI, injury severity, PTSD
and recall bias and response shift.
Overall p-values< 0.05 were considered to indicate
statistical significance, although our analysis primarily
was explorative.
Results
Study population
In total, 1518 of the 5731 invited patients participated in
the BIOS study (26.5%). Responders were significantly
younger than non-responders (p < 0.05) and significantly
more often male than non-respondents (p < 0.05). In
total, 790 patients responded on the T1 survey and 1351
patients responded on the T2 survey. However, only 550
of these patients completed the EQ-5D-3 L and EQ-VAS
at T1 and T2, the then-test EQ-5D-3 L and EQ-VAS (at
T2) and the recall EQ-5D-3 L and EQ-VAS (at T2) and
were therefore included in this study. These 550 com-
pleters were significantly more often male, significantly
younger, higher educated and had a shorter hospital stay
compared to non-completer. The completers had a
mean age of 61.0 years (SD 16.0) and slightly more than
half of the participants (56.0%) was male (Table 1). Most
participants had a middle or high-level education and
comorbidity was highly prevalent (56.2%). Patients’ me-
dian hospital stay was 4.0 (IQR 2.0–6.0) days, and most
common injuries were mild traumatic brain injury
(28.9%) and hip fracture (20.7%). Median ISS was 5.0
(IQR 4.0–9.0).
EQ-5D-3 L – conventional change versus retrospective
change
Table 2 shows the mean EQ-5D-3 L summary score at
T1 and T2, mean Then Test, mean conventional change
and retrospective change between EQ-5D-3 L summary
Fig. 1 Schematic overview of the calculations of conventional and retrospective change, recall bias and response shift
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scores at T1 and T2. Mean EQ-5D-3 L summary scores
at T1 and T2 were 0.482 (SD 0.30) and 0.735 (SD 0.24),
respectively. A lower EQ-5D-3 L summary score at T1
was associated with being younger, having an ISS ≥ 16,
not having a TBI and having PTSD three months post-
injury (all p < 0.05). Pairwise comparisons showed that
agreement between retrospective and conventional
change was fair (ICC = 0.49, p < 0.05) (see Table 2).
Retrospective change was significantly higher compared
to conventional change (Z = -5.2, p < 0.05). The differ-
ence between conventional and retrospective change was
highest among patients with ISS ≥ 16 (mean difference =
− 0.12, Z = -1.9, p = 0.058).
EQ-5D-3 L – recall bias versus response shift
Recall bias and response shift are also shown in Table 2.
Average recall bias ranged from − 0.09 (patients with
PTSD) to − 0.004 (patients with TBI). Overall, recalled
T1 EQ-5D-3 L was lower (− 0.02) than the directly
assessed EQ-5D-3 L, except for males and patients with
a high educational level (all p < 0.05). Pairwise compari-
sons showed that agreement between recall bias and re-
sponse shift was good (ICC = 0.68, p < 0.05).
Multivariate linear regression analysis indicated that in-
creasing PTSD symptoms were associated with recalling
T1 EQ-5D-3 L as lower (‘worse’) than directly assessed
EQ-5D-3 L at T1 (see Table 3). The EQ-5D-3 L dimen-
sions that differed most frequently between the directly
assessed EQ-5D-3 L at T1 and the recall test were usual
activities (36.5% of the respondents chose a different re-
sponse option on the recall test), pain and/or other com-
plaints (34.4%), self-care (28.7%) and anxiety/depression
(27.5%).
Mean response shift ranged from − 0.12 (patients with
an ISS ≥ 16) to − 0.04 (patients with a high educational
level and patients older than 65 years). Multivariate lin-
ear regression analysis indicated that increasing
Table 1 Characteristics of study population
Characteristic Study population
(n = 550)
Gender: Male 308 (56.0%)
Age (Mean, SD) 61.0 (16.0)
Education
Low 127 (23.1%)
Middle 214 (38.9%)
High 199 (36.2%)
Unknown 10 (1.8%)
Comorbidity status
No comorbidity 231 (42.0%)
Comorbidity 309 (56.2%)
Unknown 10 (1.8%)
Length of hospital stay in
days (Median, IQR)
4.0 (2.0–6.0)
Number of injuries
1 275 (50.0%)
2 129 (23.5%)
≥ 3 146 (26.5%)
Type of injuryb
Mild TBI 159 (28.9%)
Hip fracture 114 (20.7%)
Pelvic injury 71 (12.9%)
Rib fracture 71 (12.9%)
Tibia, complex foot or femur fracture 71 (12.9%)
Shoulder and upper arm injury 57 (10.4%)
Stable vertebral fracture or disc injury 40 (7.3%)
Radius, ulna or hand fracture 40 (7.3%)
Thoracic injury 31 (5.6%)
Facial fracture 29 (5.3%)
Severe TBI 15 (2.7%)
Mild abdominal injury 14 (2.5%)
Severe abdominal injury 5 (0.9%)
Spinal cord injury 2 (0.4%)
Injury Severity Score
< 8 320 (58.2%)
8–16 193 (35.1%)
≥ 16 35 (6.4%)
Unknown 2 (0.4%)
PTSD symptomsa
No PTSD (IES < 35) 451 (82.0%)
PTSD (IES≥ 35) 41 (7.5%)
Unknown 58 (10.5%)
EQ-5D-3 L scores at T1
Utility score (Mean, SD) 0.482 (0.298)
EQ-VAS (Mean, SD) 56.3 (20.5)
Table 1 Characteristics of study population (Continued)
Characteristic Study population
(n = 550)
Mobility (% reporting moderate or
extreme problems)
72.0%
Self-care (% reporting moderate or
extreme problems)
69.8%
Usual activities (% reporting moderate or
extreme problems)
85.5%
Pain/discomfort (% reporting moderate or
extreme problems)
88.0%
Anxiety/depression (% reporting moderate
or extreme problems)
24.9%
Note. SD standard deviation, IQR inter quartile range
aPTSD symptoms measured with the Impact of Event Scale (IES)
3 months post-injury
b The total number of patients by type of injury exceeds 550, because many
respondents had multiple injuries
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symptoms of PTSD were significantly associated with an
increase in response shift (see Table 4). The EQ-5D-3 L
dimensions that differed most frequently between the
directly assessed EQ-5D-3 L at T1 and the then test that
was used to assess response shift were pain and/or other
complaints (35.6% of the respondents chose a different
pain and/or other complaints response option on the
then test), daily activities (34.5%), self-care (31.3%) and
anxiety/depression (27.3%). Response shift, with an aver-
age value of − 0.06, was significantly higher than recall
bias (Z = − 4.5, p < 0.05).
EQ-VAS – conventional change versus retrospective
change
Table 5 shows the mean EQ-VAS score at T1 and the
mean conventional change and retrospective change
Table 2 Mean EQ-5D-3 L summary score at T1, conventional change and retrospective change between EQ-5D-3 L summary scores
at T1 and T2 and magnitude of recall bias and response shift
n Mean EQ-
5D T1
Mean EQ-
5D T2
Mean Then
Test
Conventional
change
Retrospective
change
ICCa Mean Recall
Test
Recall
bias
Response
shift
ICCb
Total 550c 0.482
(SD 0.30)
0.735
(SD 0.24)
0.419
(SD 0.35)
0.254
(SD 0.29)
0.316
(SD 0.31)
0.489* 0.462
(SD 0.34)
−0.020
(SD 0.30)
− 0.063
(SD 0.31)
0.681*
Gender
Males 308 0.500
(SD 0.31)
0.741
(SD 0.25)
0.450
(SD 0.36)
0.242
(SD 0.31)
0.292
(SD 0.33)
0.545* 0.506
(SD 0.35)
0.007
(SD 0.31)
−0.050
(SD 0.30)
0.705*
Females 242 0.459
(SD 0.28)
0.728
(SD 0.23)
0.380
(SD 0.33)
0.269
(0.26)
0.348
(SD 0.30)
0.391* 0.405
(SD 0.33)
−0.054
(SD 0.29)
− 0.079
(SD 0.31)
0.648*
Age
< 65 years 285 0.452
(SD 0.29)
0.741
(SD 0.24)
0.373
(SD 0.34)
0.289
(SD 0.29)
0.369
(SD 0.32)
0.516* 0.425
(SD 0.34)
−0.028
(SD 0.31)
− 0.080
(SD 0.30)
0.749*
65+ years 265 0.513
(SD 0.30)
0.729
(SD 0.24)
0.469
(SD 0.35)
0.216
(SD 0.29)
0.260
(SD 0.30)
0.435* 0.501
(SD 0.35)
−0.012
(SD 0.29)
− 0.044
(SD 0.31)
0.608*
Educational level1
Low 127 0.503
(SD 0.33)
0.697
(SD 0.26)
0.443
(SD 0.37)
0.193
(SD 0.30)
0.254
(SD 0.30)
0.439* 0.489
(SD 0.35)
−0.015
(SD 0.32)
− 0.060
(SD 0.32)
0.661*
Middle 214 0.492
(SD 0.30)
0.740
(SD 0.25)
0.406
(SD 0.350)
0.248
(SD 0.30)
0.334
(SD 0.30)
0.458* 0.451
(SD 0.36)
−0.041
(SD 0.32)
−0.086
(SD 0.31)
0.717*
High 199 0.447
(SD 0.27)
0.752
(SD 0.23)
0.403
(SD 0.34)
0.305
(SD 0.26)
0.349
(SD 0.33)
0.543* 0.448
(SD 0.33)
0.012
(SD 0.26)
−0.044
(SD 0.28)
0.650*
Comorbidity status2
No
comorbidity
231 0.499
(SD 0.28)
0.784
(SD 0.24)
0.437
(SD 0.33)
0.285
(SD 0.28)
0.347
(SD 0.31)
0.532* 0.480
(SD 0.32)
−0.019
(SD 0.30)
−0.062
(SD 0.29)
0.736*
Comorbidity 309 0.472
(SD 0.31)
0.702
(SD 0.24)
0.407
(SD 0.36)
0.230
(SD 0.29)
0.295
(SD 0.32)
0.450* 0.452
(SD 0.36)
−0.020
(SD 0.30)
−0.065
(SD 0.32)
0.655*
ISS3
ISS < 16 513 0.493
(SD 0.29)
0.741
(SD 0.24)
0.433
(SD 0.34)
0.248
(SD 0.29)
0.308
(SD 0.31)
0.503* 0.474
(SD 0.34)
−0.019
(SD 0.30)
−0.060
(SD 0.30)
0.670*
ISS > = 16 35 0.350
(SD 0.30)
0.659
(SD 0.28)
0.229
(SD 0.40)
0.309
(SD 0.29)
0.429
(SD 0.36)
0.315* 0.289
(SD 0.38)
−0.061
(SD 0.34)
−0.120
(SD 0.39)
0.740*
TBI
No TBI 384 0.432
(SD 0.28)
0.721
(SD 0.24)
0.383
(SD 0.33)
0.290
(SD 0.28)
0.338
(SD 0.31)
0.461* 0.428
(SD 0.33)
−0.004
(SD 0.30)
−0.048
(SD 0.31)
0.656*
TBI 166 0.598
(SD 0.30)
0.768
(SD 0.25)
0.501
(SD 0.38)
0.171
(SD 0.28)
0.267
(SD 0.31)
0.525* 0.539
(SD 0.37)
−0.058
(SD 0.29)
−0.096
(SD 0.29)
0.742*
PTSD symptoms4d
No PTSD 451 0.490
(SD 0.29)
0.759
(SD 0.22)
0.423
(SD 0.34)
0.269
(SD 0.28)
0.337
(SD 0.31)
0.518* 0.471
(SD 0.34)
−0.019
(SD 0.30)
−0.068
(SD 0.29)
0.684*
PTSD 41 0.345
(SD 0.35)
0.487
(SD 0.35)
0.270
(SD 0.43)
0.142
(SD 0.41)
0.216
(SD 0.35)
0.294* 0.252
(SD 0.36)
−0.093
(SD 0.37)
− 0.075
(SD 0.45)
0.780*
SD standard deviation, ICC intraclass correlation coefficient, ISS injury severity score, TBI traumatic brain injury, PTSD posttraumatic stress disorder
a ICC corresponds to the correlation between conventional and retrospective change
b ICC corresponds to the correlation between recall bias and response shift
cPatients who completed the EQ-5D at 1 week and 3months and the then-test and recall-test for 1 week at 3 months after sustaining an injury
dPTSD symptoms measured with the Impact of Event Scale (IES) 3 months post-injury
110 missing values, 210 missing values, 32 missing values, 458 missing values
*p < 0.05
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between EQ-VAS scores at T1 and T2. Mean EQ-VAS
score improved from T1 (56.3; SD 20) to T2 (72.6; SD
17). A lower EQ-VAS score at T1 was associated with
female gender, younger age, having an ISS ≥ 16 and not
having a TBI (all p < 0.05). Individual agreement be-
tween retrospective and conventional change in EQ-
VAS was fair (ICC = 0.483, p < 0.05) (see Table 5). Retro-
spective change in EQ-VAS score was significantly
higher compared to conventional change (Z = -2.1, p <
0.05). The difference between conventional and retro-
spective change in EQ-VAS was particularly large among
patients with PTSD (difference = − 7.7, Z = -2.4, p <
0.05), patients with an ISS ≥ 16 (mean difference = − 6.6,
Z = -1.7, p = 0.09) and patients with a TBI (mean differ-
ence = − 4.7, Z = -2.9, p < 0.05).
EQ-VAS – recall bias versus response shift
On average, the recalled T1 EQ-VAS was 0.6 lower
(‘worse’) than directly assessed T1 EQ-VAS (p < 0.05).
The mean recall bias ranged from − 7.3 for patients with
PTSD to − 0.3 for patients with comorbidity. Overall,
recalled T1 EQ-5D-3 L was lower than the directly
assessed EQ-5D-3 L, except for patients aged 65 and older,
patients without TBI and patients with a high educational
level (all p < 0.05). Pairwise comparisons showed that
agreement between recall bias and response shift was ex-
cellent (ICC = 0.78, p < 0.05). Multivariate linear regres-
sion analysis indicated that increasing PTSD symptoms
and having TBI was significantly associated with a lower
recalled T1 EQ-VAS compared to directly assessed EQ-
VAS (see Table 6). With an average value of − 1.6, re-
sponse shift was higher than recall bias, but this difference
was not significant (Z = -0.635, p = 0.53). Response shift
was highest for patients with PTSD (mean: − 7.6), patients
with an ISS ≥ 16 (mean: − 6.7) and patients with TBI
(mean: − 4.8) and lowest for patients without TBI (mean:
− 0.2) and patients older than 65 years (mean: − 0.3).
Multivariate linear regression analysis indicated that
Table 3 Multivariate models for recall bias on the EQ-5D-3 L summary score
Initial model Final model
Unstandardized B p-value Unstandardized B p-value
Constant 0.070 0.342 0.009 0.603
Agea 0.000 0.769
Sex (male/female) −0.044 0.119
Education (dichotomized) 0.025 0.379
Comorbidity (no/yes) 0.031 0.312
TBI (no/yes) −0.051 0.093
ISSa 0.001 0.764
PTSDa −0.003 0.001 −0.004 < 0.001
F value 2.96 0.05 13.73 < 0.001
Adjusted R-square 0.028 0.026
a Continuous variables
Table 4 Multivariate models for response shift based on the EQ-5D-3 L summary score
Initial model Final model
Unstandardized B p-value Unstandardized B p-value
Constant − 0.039 0.603 −0.049
Agea < 0.001 0.750
Sex (male/female) −0.025 0.387
Education (dichotomized) 0.037 0.201
Comorbidity (no/yes) 0.002 0.945
TBI (no/yes) −0.039 0.200
ISSa 0.000 0.983
PTSDa −0.002 0.037 −0.002 0.016
F value 1.40 0.20 5.83 0.016
Adjusted R-square 0.006 0.010
a Continuous variables
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increasing PTSD symptoms and having TBI was associ-
ated with response shift (see Table 7).
Discussion
Our study showed that retrospective change in HRQL
exceeded conventional change and that, at the individual
level, agreement between conventional and retrospective
change was only fair for both the EQ-5D-3 L summary
score and the EQ-VAS. Response shift, more than recall
bias, modified the reported retrospective outcome.
The relative magnitude of recall bias and response
shift was higher when measured with the EQ-VAS
Table 5 Mean EQ-VAS score at T1, conventional change and retrospective change between EQ-VAS score at T1 and T2 and
magnitude of recall bias and response shift
EQ-VAS
T1
Mean EQ-
5D T2
Mean Then Test Conventional
change
Retrospective
change
ICCα Mean Recall
Test
Recall
bias
Response
shift
ICC§
Total 56.3$
(SD 20)
72.6
(SD 17.0)
54.7
(SD 21.0)
16.3
(SD 19)
17.9
(SD 18)
0.483* 55.7
(SD 21.0)
−0.62
(SD 20)
−1.59
(SD 19)
0.783*
Gender
Males 58.3
(SD 21)
73.4
(SD 17.0)
56.4
(SD 22.5)
15.0
(SD 12)
17.0
(SD 14)
0.464* 57.6
(SD 22.5)
−0.74
(SD 21)
−1.94
(SD 19)
0.793*
Females 53.8
(SD 19)
71.7
(SD 16.9)
52.7
(SD 18.8)
17.9
(SD 19)
19.0
(SD 18)
0.503* 53.3
(SD 18.7)
−0.46
(SD 17)
−1.14
(SD 19)
0.768*
Age
< 65 years 54.1 (SD 20) 72.1
(SD 17.9)
51.4
(SD 21.2)
17.9
(SD 19)
20.7
(SD 19)
0.459* 51.7
(SD 20.9)
−2.46
(SD 18)
−2.74
(SD 20)
0.740*
65+ years 58.7
(SD 21)
73.2
(SD 15.9)
58.3
(SD 20.2)
14.5
(SD 20)
14.8
(SD 16)
0.498* 60.0
(SD 20.2)
1.362
(SD 21)
−0.34
(SD 18)
0.825*
Educational level1
Low 56.1 (SD 21) 69.7
(SD 16.9)
54.6
(SD 19.6)
13.6
(SD 21)
15.1
(SD 19)
0.561* 55.8
(SD 20.7)
−0.32
(SD 20)
−1.51
(SD 19)
0.798*
Middle 57.4 (SD 21) 74.3
(SD 17.2)
54.8
(SD 22.7)
17.0
(SD 20)
19.6 (SD 18) 0.402* 55.7
(SD 22.5)
−1.71
(SD 21)
−2.61
(SD 21)
0.773*
High 55.1 (SD 20) 72.8
(SD 16.3)
54.3
(SD 20.0)
17.7
(SD 17)
18.5
(SD 16)
0.519* 55.4
(SD 19.6)
0.32
(SD 18)
−0.80
(SD 16)
0.784*
Comorbidity status2
No
comorbidity
57.3
(SD 20)
77.0
(SD 16.3)
56.2
(SD 20.9)
19.7
(SD 20)
20.8
(SD 19)
0.524* 56.7
(SD 20.5)
−0.58
(SD 20)
−1.06
(SD 19)
0.772*
Comorbidity 55.6
(SD 20)
69.6
(SD 16.6)
53.9
(SD 20.8)
14.1
(SD 19)
15.7
(SD 17)
0.421* 55.3
(SD 21.1)
−0.27
(SD 20)
−1.676 (SD 19) 0.793*
ISS3
ISS < 16 57.3
(SD 20)
73.1
(SD 16.8)
55.9
(SD 20.3)
15.8
(SD 19)
17.11
(SD 17)
0.503* 56.6
(SD 20.4)
−0.69
(SD 19)
−1.31
(SD 19)
0.802*
ISS > = 16 44.6
(SD 20)
66.5
(SD 18.3)
37.9
(SD 23.6)
21.9
(SD 23)
28.5
(SD 19)
0.199 43.8
(SD 25.3)
−0.77
(SD 29)
−6.66
(SD 27)
0.661*
TBI
No TBI 54.5
(SD 20)
71.8
(SD 17.0)
54.3
(SD 20.6)
17.3
(SD 20)
17.5
(SD 18)
0.503* 55.1
(SD 20.5)
0.57
(SD 20)
−0.22
(SD 19)
0.787*
TBI 60.5
(SD 21)
74.4
(SD 16.7)
55.8
(SD 22.1)
13.9
(SD 17)
18.6
(SD 17)
0.445* 57.2
(SD 22.2)
−3.37
(SD 19)
−4.75
(SD 18)
0.765*
PTSD symptoms4&
No PTSD 56.9
(SD 20)
73.7
(SD 16.3)
55.6
(SD 21.1)
16.8
(SD 19)
18.2
(SD 18)
0.495* 56.2
(SD 20.8)
−0.72
(SD 19)
−1.39
(SD 18)
0.774*
PTSD 51.8
(SD 21)
58.1
(SD 17.7)
44.2
(SD 20.8)
6.2
(SD 22)
13.9
(SD 19)
0.556* 44.5
(SD 21.2)
−7.29
(SD 20)
−7.61
(SD 19)
0.753*
SD standard deviation, ICC intraclass correlation coefficient, ISS injury severity score, TBI traumatic brain injury, PTSD posttraumatic stress disorder
α ICC corresponds to the correlation between conventional and retrospective change
§ ICC corresponds to the correlation between recall bias and response shift
$Patients who completed the EQ-5D at 1 week and 3months and the then-test and recall-test for 1 week at 3 months after sustaining an injury
&PTSD symptoms measured with the Impact of Event Scale (IES) 3 months post-injury
110 missing values, 210 missing values, 32 missing values, 458 missing values
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compared to the EQ-5D-3 L summary score. This may
be due to the fact that the restricted range of responses
of the EQ-5D-3 L may lead to smaller variability in
scores compared to the continuous EQ-VAS [13]. The
subjectivity of the scale, which is higher for VAS com-
pared to the classification-like EQ-5D-3 L, played a
much smaller role than expected. We expected that the
individual agreement between conventional and retro-
spective change would be higher for the EQ-5D-3 L
summary score compared to the EQ-VAS; however, our
findings showed that the individual agreement was
similar.
In agreement to our expectations, response shift was
higher among trauma patients with severe injuries (ISS ≥
16). This indicates that high impact trauma requires
more adaptation to one’s health status compared to less
severe trauma. Our findings also showed that, rela-
tively shortly after sustaining injury, the magnitude of
response shift is already quite large. This is in agree-
ment with a study that assessed response shift among
individuals with stroke and that found evidence of
similarly large magnitude of response shift 24 weeks
post-stroke [35].
Conversely to our expectations we did not find that
the size of recall bias was higher in older respondents
compared to their younger counterparts. This finding
may be explained by participation bias. In our study, re-
sponse rate was rather low and, possibly, the elderly that
did participate may not have been representative of elder
trauma patients in the sense that the elderly respondents
may experience less memory problems compared to the
elderly non-respondents.
Table 6 Multivariate models for response shift based on the EQ-VAS
Initial model Final model
Unstandardized B p-value Unstandardized B p-value
Constant −5.977 0.342 0.482 0.674
Agea 0.059 0.769
Sex (male/female) 2.146 0.119
Education (dichotomized) 1.482 0.379
Comorbidity (no/yes) 0.351 0.312
TBI (no/yes) −3.922 0.093 −4.037 0.032
ISSa −0.138 0.764
PTSDa −0.142 0.001 −0.135 0.029
F value 2.15 0.038 5.09 0.007
Adjusted R-square 0.017 0.017
a Continuous variables
Table 7 Multivariate models for recall bias based on the EQ-VAS
Initial model Final model
Unstandardized B p-value Unstandardized B p-value
Constant −8.476 0.069 1.127 0.333
Agea 0.083 0.178
Sex 1.727 0.331
Education (dichotomized) 1.889 0.299
Comorbidity (yes/no) 1.400 0.474
TBI (yes/no) −3.685 0.055 −3.808 0.047
ISSa 0.100 0.521
PTSDa −0.147 0.022 −0.134 0.033
F value 2.16 0.036 4.62 0.010
Adjusted R-square 0.017 0.015
a Continuous variables
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We did find that response shift increased with increas-
ing PTSD symptoms. This may indicate that symptoms
of PTSD affect cognitive dissonance between the actual
health state of the respondent and the desired health
state. Second, both TBI and PTSD were positively asso-
ciated with recall bias. Similarly to TBI, PTSD is associ-
ated with impairments in cognitive functioning [36–38].
Our findings clearly confirm that cognitive impairment
is a non-trivial factor in research where recall bias may
occur.
Agreement between conventional and retrospective
change in HRQL was similar to the agreement reported
by McPhail et al. and, similarly to McPhail et al., we
found a higher retrospective change than conventional
change for both the EQ-5D-3 L summary score and EQ-
5D-3 L [10]. However, McPhail et al. reported a much
larger difference between conventional and retrospective
change and higher recall bias. This difference in findings
may be explained by the difference in study population
and/or timing of HRQL assessments. McPhail et al.
studied hospitalized elderly, whereas we studied hospi-
talized trauma patients aged 18 and older. Higher age of
the respondents may have contributed to the difference
in conventional and retrospective change and magnitude
of recall bias, although our study did not show import-
ant differences between conventional and retrospective
change, recall bias or response shift in younger versus
older trauma patients. With regards to the timing of
HRQL assessment, McPhail et al. measured HRQL im-
mediately after hospital admission (T1) and immediately
after discharge (T2), whereas our first measurement of
HRQL was 1 week post-injury. As a result, the change in
HRQL at T1 and T2, as measured by McPhail et al., may
have been much larger and subsequently also the contri-
bution of recall bias and response shift to the difference
between conventional and retrospective change in
HRQL.
Strengths and limitations
Strengths of our study were the meticulous protocol and
the regional coverage, with a high number of respon-
dents. The combined use of subjective and a
classification-like scales reinforced analytical opportun-
ities as shown. The high number of respondents allowed
us to test for differences between conventional and
retrospective change in HRQL and assess recall bias and
response shift for specific subgroups of trauma patients,
such as trauma patients with severe injury and patients
with TBI. The use of the EQ-5D-3 L and EQ-VAS
allowed us to compare differences between conventional
and retrospective change in HRQL and contribution of
recall bias and response shift on a subjective scale and a
classification like scale.
A limitation of our study was the uniform follow-up
time (3 months), which limited conclusions on duration-
dependence of the bias effects. In our study, the time be-
tween first and second measurement was 3 months.
Stronger recall bias may be expected over longer pe-
riods, with perhaps recall becoming more important
than response shift [11]. If e.g. 12 months instead of 3
months has been chosen as interval, the effect of recall
bias might have been more pronounced.
A second limitation of our study was that the T2
survey included the EQ-5D-3 L and EQ-VAS for the
direct measurement of current HRQL as well as the
recall and then-test regarding the respondents’ HRQL
at T1. This was a challenging task. This meant that
the respondents had to fill out several similarly for-
mulated questions. This may have affected both the
number of respondents with complete responses, as
well as the quality of the responses. Since we admin-
istered stand-alone paper-and-pencil surveys, we were
not able to verify if the respondents understood the
recall and then test and the difference between these
two questionnaires.
A third limitation is the use of EQ-5D-3 L rather
than the EQ-5D-5 L. As the EQ-5D-5 L has five re-
sponse options instead of three with more sensitivity
and precision, contrasts could have been larger in
that case [39–41]. For future studies that aim to in-
vestigate recall bias and response shift we recommend
to use the EQ-5D-5 L.
Implications for clinical practice
The findings of our study confirm that, in our sample
of trauma patients, there was disagreement between
conventional and retrospective change of HRQL and
that recall bias and response shift both contributed to
this difference. This is important to take into account
when change in HRQL is used to evaluate health in-
terventions in this patient group. Whether conven-
tional or retrospective change should be used for the
evaluation depends strongly on the aims of the inter-
vention and the characteristics of the patients, as well
as which perspective of change is the most important
to various stakeholders, as was also pointed out by
McPhail et al. [10].
Conclusions
We conclude that, compared to recall bias, response
shift contributed more to the disagreement between
conventional and retrospective change in EQ-5D-3 L
summary score and EQ-VAS. Predictable subgroups
of trauma patients were more susceptible to recall
bias and response shift, such as patients who sus-
tained TBI and patients with PTSD symptoms 3
months post-injury.
Haagsma et al. Health and Quality of Life Outcomes          (2020) 18:157 Page 11 of 13
Abbreviations
AIS: Abbreviated Injury Scale; ANOVA: One-way analysis of variance;
BIOS: Brabant Injury Outcome Surveillance; ED: Emergency Department;
HRQL: Health-related quality of life; ICC: Intraclass correlation coefficient;
ICU: Intensive Care unit; IES: Impact of event scale; ISS: Injury Severity Score;
IQR: Interquartile range; PTSD: Posttraumatic stress disorder; SD: Standard
deviation; T1: Postal questionnaire 1 week after the initial treatment of the
injury; T2: Postal questionnaire 3 months after the initial treatment of the
injury; TBI: Traumatic brain injury; VAS: Visual analogue scale
Authors’ contributions
JH, GB, MdJ and SP conceptualized the design of the study. MdJ and SP
coordinated the collection of the data. IS and JH analysed the data. JH, IS,
GB, MdJ and SP interpreted the data. JH, IS and GB drafted the manuscript.
JH, GB, IS, MdJ and SP revised the manuscript critically for important
intellectual content. IS, GB, MdJ and SP have given final approval of the
version of the manuscript that was submitted to be published. Each author
agreed to be accountable for all aspects of the work in ensuring that
questions related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved. The author(s) read and approved
the final manuscript.
Funding
This study was funded by the EuroQoL group (Grant number EQ Project
2016160).
Availability of data and materials
The datasets used and/or analysed during the current study are available
from the corresponding author on reasonable request.
Ethics approval and consent to participate
This study was approved by the Medical Ethics Committee Brabant, the
Netherlands. Patients needed to give permission for participation in the BIOS
study. Informed consent forms were sent together with the T1 questionnaire
or together with questionnaires sent at later time points when the patient
did not respond to the T1 questionnaire.
Consent for publication
Not applicable.
Competing interests
This study was funded by the EuroQoL group (Grant number EQ Project
2016160), of which GJB is a member.
Author details
1Department of Public Health, Erasmus MC University Medical Center
Rotterdam, P.O. Box 2040, 3000, CA, Rotterdam, The Netherlands.
2Association of Dutch Burn Centres, Maasstad Hospital, Rotterdam, The
Netherlands. 3Department Trauma TopCare, ETZ Hospital, Tilburg, The
Netherlands.
Received: 10 April 2019 Accepted: 11 May 2020
References
1. Polinder S, Haagsma JA, Belt E, Lyons RA, Erasmus V, Lund J, van Beeck EF.
A systematic review of studies measuring health-related quality of life of
general injury populations. BMC Public Health. 2010;10:783.
2. Sullivan M. The new subjective medicine: taking the patient's point of view
on health care and health. Soc Sci Med. 2003;56:1595–604.
3. Fanning J, Walkup MP, Ambrosius WT, Brawley LR, Ip EH, Marsh AP, Rejeski
WJ. Change in health-related quality of life and social cognitive outcomes
in obese, older adults in a randomized controlled weight loss trial: does
physical activity behavior matter? J Behav Med. 2018;41:299–308.
4. Liimatta H, Lampela P, Laitinen-Parkkonen P, Pitkala KH. Effects of preventive
home visits on health-related quality-of-life and mortality in home-dwelling
older adults. Scand J Prim Health Care. 2019;37:90–7.
5. Dhanda R, Varghese D, Nadipelli VR, Fava M, Joshi N, Solem CT, Graham JA,
Learned SM, Heidbreder C. Patient-reported outcomes in schizophrenia
patients treated with once-monthly extended-release risperidone in a long-
term clinical study. Patient Prefer Adherence. 2019;13:1037–50.
6. Khalil JG, Smuck M, Koreckij T, Keel J, Beall D, Goodman B, Kalapos P,
Nguyen D, Garfin S, Investigators IT. A prospective, randomized, multicenter
study of intraosseous basivertebral nerve ablation for the treatment of
chronic low back pain. Spine J. 2019;19:1620–32.
7. Brahmer JR, Rodriguez-Abreu D, Robinson AG, Hui R, Csoszi T, Fulop A,
Gottfried M, Peled N, Tafreshi A, Cuffe S, et al. Health-related quality-of-life
results for pembrolizumab versus chemotherapy in advanced, PD-L1-
positive NSCLC (KEYNOTE-024): a multicentre, international, randomised,
open-label phase 3 trial. Lancet Oncol. 2017;18:1600–9.
8. Gabbe BJ, Simpson PM, Harrison JE, Lyons RA, Ameratunga S, Ponsford J,
Fitzgerald M, Judson R, Collie A, Cameron PA. Return to work and functional
outcomes after major trauma. Ann Surg. 2016;263:623–32.
9. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change
in health-related quality of life. J Clin Epidemiol. 2003;56:395–407.
10. McPhail S, Haines T. Response shift, recall bias and their effect on measuring
change in health-related quality of life amongst older hospital patients.
Health Qual Life Outcomes. 2010;8:65.
11. Schmier JK, Halpern MT. Patient recall and recall bias of health state and
health status. Expert Rev Pharmacoecon Outcomes Res. 2004;4:159–63.
12. Stull DE, Leidy NK, Parasuraman B, Chassany O. Optimal recall periods for
patient-reported outcomes: challenges and potential solutions. Curr Med
Res Opin. 2009;25:929–42.
13. Kwong E, Neuburger J, Black N. Agreement between retrospectively and
contemporaneously collected patient-reported outcome measures (PROMs)
in hip and knee replacement patients. Qual Life Res. 2018;27(7):1845-54.
14. Howell J, Xu M, Duncan CP, Masri BA, Garbuz DS. A comparison between
patient recall and concurrent measurement of preoperative quality of life
outcome in total hip arthroplasty. J Arthroplast. 2008;23:843–9.
15. Topp J, Andrees V, Heesen C, Augustin M, Blome C. Recall of health-related
quality of life: how does memory affect the SF-6D in patients with psoriasis
or multiple sclerosis? A prospective observational study in Germany. BMJ
Open. 2019;9:e032859.
16. Litwin MS, McGuigan KA. Accuracy of recall in health-related quality-of-life
assessment among men treated for prostate cancer. J Clin Oncol. 1999;17:
2882–8.
17. Haagsma J, Bonsel G, de Jongh M, Polinder S. Agreement between
retrospectively assessed health-related quality of life collected 1 week and
12 months post-injury: an observational follow-up study. Health Qual Life
Outcomes. 2019;17:70.
18. Silverberg ND, Iverson GL, Brubacher JR, Holland E, Hoshino LC, Aquino A,
Lange RT. The nature and clinical significance of Preinjury recall Bias
following mild traumatic brain injury. J Head Trauma Rehabil. 2016;31:388–
96.
19. Schwartz CE, Sprangers MAG. Methodological approaches for assessing
response shift in longitudinal health-related quality-of-life research. Soc Sci
Med. 1999;48:1531–48.
20. Sprangers MAG, Schwartz CE. Integrating response shift into health-related
quality of life research: a theoretical model. Soc Sci Med. 1999;48:1507–15.
21. Schwartz CE, Sprangers MAG, Carey A, Reed G. Exploring response shift in
longitudinal data. Psychol Health. 2003;19:51–69.
22. de Jongh MAC, Kruithof N, Gosens T, van de Ree CLP, de Munter L,
Brouwers L, Polinder S, Lansink KWW. Prevalence, recovery patterns and
predictors of quality of life and costs after non-fatal injury: the Brabant
injury outcome surveillance (BIOS) study. Inj Prev. 2017;23:59.
23. Centraal Bureau voor de Statistiek. Permanent onderzoek leefsituatie.
Voorburg/Heerlen: Statistics Netherlands (CBS); 2003.
24. Mosby. Mosby's Medical Dictionary. 9th ed; 2012.
25. Brooks R, Group E. EuroQol: the current state of play. Health Policy. 1996;37:
53–72.
26. Rabin R, Fd C. EQ-SD: a measure of health status from the EuroQol group.
Ann Med. 2001;33:337–43.
27. Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997:
1095–108.
28. Horowitz M, Wilner N, Alvarez W. Impact of event scale: a measure of
subjective stress. Psychosom Med. 1979;41:209–18.
29. Wohlfarth TD, van den Brink W, Winkel FW, ter Smitten M. Screening for
posttraumatic stress disorder: an evaluation of two self-report scales among
crime victims. Psychol Assess. 2003;15:101–9.
30. Baker SP, o'Neill B, Haddon W Jr, Long WB. The injury severity score: a
method for describing patients with multiple injuries and evaluating
emergency care. J Trauma. 1974;14:187–96.
Haagsma et al. Health and Quality of Life Outcomes          (2020) 18:157 Page 12 of 13
31. Gennarelli TA, Wodzin E. AIS 2005: A contemporary injury scale. Injury.
2006(37):1083–91.
32. Boyd CR, Tolson MA, Copes WS. Evaluating trauma care: the TRISS method.
Trauma score and the injury severity score. J Trauma. 1987;27:370–8.
33. Bartko JJ. The intraclass correlation coefficient as a measure of reliability.
Psychol Rep. 1966;19:3–11.
34. Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating normed
and standardized assessment instruments in psychology. Psychol Assess.
1994;6:284.
35. Ahmed S, Mayo NE, Wood-Dauphinee S, Hanley JA, Cohen SR. Response
shift influenced estimates of change in health-related quality of life
poststroke. J Clin Epidemiol. 2004;57:561–70.
36. Aupperle RL, Melrose AJ, Stein MB, Paulus MP. Executive function and PTSD:
disengaging from trauma. Neuropharmacology. 2012;62:686–94.
37. Qureshi SU, Long ME, Bradshaw MR, Pyne JM, Magruder KM, Kimbrell T,
Hudson TJ, Jawaid A, Schulz PE, Kunik ME. Does PTSD impair cognition
beyond the effect of trauma? J Neuropsychiatry Clin Neurosci. 2011;23:16–28.
38. Schuitevoerder S, Rosen JW, Twamley EW, Ayers CR, Sones H, Lohr JB,
Goetter EM, Fonzo GA, Holloway KJ, Thorp SR. A meta-analysis of cognitive
functioning in older adults with PTSD. J Anxiety Disord. 2013;27:550–8.
39. Agborsangaya CB, Lahtinen M, Cooke T, Johnson JA. Comparing the EQ-5D
3L and 5L: measurement properties and association with chronic conditions
and multimorbidity in the general population. Health Qual Life Outcomes.
2014;12:74.
40. Janssen MF, Bonsel GJ, Luo N. Is EQ-5D-5L better than EQ-5D-3L? A head-
to-head comparison of descriptive systems and value sets from seven
countries. Pharmacoeconomics. 2018;36:675–97.
41. Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L,
Swinburn P, Busschbach J. Measurement properties of the EQ-5D-5L
compared to the EQ-5D-3L across eight patient groups: a multi-country
study. Qual Life Res. 2013;22:1717–27.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Haagsma et al. Health and Quality of Life Outcomes          (2020) 18:157 Page 13 of 13
